Internal Medicine, Rheumatology · Sherman, TX
NPI
1730187816
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1107 Sara Swamy Dr
Sherman, TX, 75090
Phone (903) 891-9303
Groups this clinician bills Medicare through
Medicare paid, 2024
$336K
32,167 services
Medicare patients, 2024
833
Average age 74
Drug cost, 2024
$2.8M
5,428 prescriptions
Company payments, 2025
$65.86
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pratap R Tummala was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 22,600 times for 11 patients. In total Pratap R Tummala billed 32,167 services in 39 codes, and Medicare paid $336K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 22,600 | 11 | $3.62 | $82K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,357 | 317 | $0.71 | $1,679 |
| 99213 Office E&M - Established | Office | 1,545 | 642 | $59.25 | $92K |
| 36415 Venipuncture Blood Collection | Office | 947 | 454 | $8.50 | $8,049 |
| 73130 X-ray - Upper Extremity | Office | 407 | 211 | $25.30 | $10K |
| 99212 Office E&M - Established | Office | 343 | 173 | $34.97 | $12K |
| 20610 Joint Injection | Office | 305 | 159 | $50.49 | $15K |
| 73630 X-ray - Lower Extremity | Office | 248 | 130 | $23.45 | $5,816 |
| 99214 Office E&M - Established | Office | 207 | 156 | $88.49 | $18K |
| 96372 Injection Administration | Office | 204 | 92 | $10.09 | $2,058 |
| 20611 Joint Injection | Office | 176 | 107 | $68.90 | $12K |
| 99204 Office E&M - New | Office | 112 | 112 | $115.61 | $13K |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 70 | 13 | $55.10 | $3,857 |
| 96413 Chemotherapy Administration | Office | 52 | 12 | $95.74 | $4,978 |
| 99203 Office E&M - New | Office | 51 | 51 | $67.01 | $3,418 |
By year: 2022 $416K for 35,939 services; 2023 $396K for 42,042 services; 2024 $336K for 32,167 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 947 | 454 | $8.50 | $8,049 |
Medicare prescription drug claims, 2024
In 2024, the drug Pratap R Tummala prescribed most often to Medicare patients was Leflunomide, with 538 prescriptions and refills. In total Pratap R Tummala wrote 5,428 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Leflunomide Generic | 538 | 960 | 134 | $19K |
| Gabapentin Generic | 531 | 806 | 134 | $4,595 |
| Methotrexate Methotrexate Sodium | 503 | 914 | 131 | $8,422 |
| Prednisone Generic | 466 | 643 | 130 | $2,698 |
| Duloxetine Hcl Generic | 437 | 660 | 99 | $9,458 |
| Hydroxychloroquine Sulfate Generic | 414 | 711 | 92 | $12K |
| Sulfasalazine Generic | 372 | 588 | 94 | $6,294 |
| Celecoxib Generic | 364 | 445 | 98 | $4,139 |
| Trazodone Hcl Generic | 144 | 228 | 34 | $637 |
| Methylprednisolone Generic | 130 | 132 | 93 | $848 |
| Allopurinol Generic | 126 | 287 | 30 | $990 |
| Folic Acid Generic | 105 | 219 | 31 | $835 |
| Tramadol Hcl Generic | 98 | 98 | 26 | $296 |
| Meloxicam Generic | 98 | 144 | 40 | $372 |
| Humira(Cf) Pen Adalimumab | 87 | 90 | 15 | $629K |
Brand drugs: - claims; generic drugs: 4,588 claims; opioid claims: 166.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pratap R Tummala $65.86 ($65.86 in general payments such as food, travel and fees) from 2 companies. The largest payer was Pfizer Inc. with $35.16.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.